Contrast Transthoracic Echocardiography Using 50% Glucose as a Contrast Agent for Screening of a Patent Foramen Ovale

Ultrasound Med Biol. 2018 Nov;44(11):2267-2273. doi: 10.1016/j.ultrasmedbio.2018.06.007. Epub 2018 Aug 2.

Abstract

A patent foramen ovale (PFO) is considered a risk factor for neurologic events. The goal of the study described here was to assess the feasibility, advantages, diagnostic sensitivity and accuracy of contrast transthoracic echocardiography examination (cTTE) using 50% glucose as a contrast agent in comparison with the use of agitated saline as contrast to screen for PFO. In our study, we found that the peak time, effective duration and duration of microbubbles produced by 50% glucose were all longer than those produced by the physiologic saline. The sensitivities for detection of PFO with cTTE using physiologic saline and 50% glucose as contrast were 83% (20/24) and 100% (24/24), respectively. TEE suggested a PFO in 24 patients in two groups. Use of 50% glucose as a contrast agent in cTTE examination enables ultrasound technicians to easily observe the right-to-left shunt across the PFO. However, the sensitivities for detection of PFO with cTTE using 50% glucose did not statistically significantly differ from those for physiologic saline.

Keywords: Contrast; Echocardiogram; Echocardiography; Patent foramen ovale.

MeSH terms

  • Adolescent
  • Adult
  • Contrast Media*
  • Diving
  • Echocardiography / methods*
  • Feasibility Studies
  • Female
  • Foramen Ovale / abnormalities
  • Foramen Ovale / diagnostic imaging
  • Foramen Ovale, Patent / diagnostic imaging*
  • Glucose*
  • Humans
  • Image Enhancement / methods*
  • Male
  • Microbubbles
  • Middle Aged
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Young Adult

Substances

  • Contrast Media
  • Glucose